CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Exela Pharma Sciences, LLC v. Avadel Legacy Pharmaceuticals, LLC

1:20-cv-00024

Overview

Case Number 1:20-cv-00024
Filing Date 2020-01-07
Status Terminated
Termination Date 2020-07-08
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Avadel US Holdings Inc. NPE (Patent Assertion Entity)

Represented By

1 Attorneys Listed

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Avadel Legacy Pharmaceuticals, LLC Operating Company

Represented By

1 Attorneys Listed

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Plaintiff

Exela Pharma Sciences, LLC Operating Company

Represented By

1 Attorneys Listed

Robert M. Oakes

Fish & Richardson, P.C.

Tel: +1 (302) 778-8477

222 Delaware Avenue, 17th Floor, P.O. Box 1114

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 21 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials 3 proceedings
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (21): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (3 found):
PTAB: 3
USPTO PTAB Trial 2024-02-08
PGR2024-00016

Nexus Pharmaceuticals LLC v. Exela Pharma Sciences, LLC

U.S. Continuation Sibling (11642370)
Status: Institution Denied
USPTO PTAB Trial 2020-06-08
PGR2020-00068

Eton Pharmaceuticals Inc. v. Exela Pharma Sciences, LLC

U.S. Continuation Sibling (10583155)
Status: Institution Denied
USPTO PTAB Trial 2020-05-19
PGR2020-00064

Eton Pharmaceuticals, Inc. v. Exela Pharma Sciences, LLC

Asserted Patent
Status: Institution Denied
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US10478453
Stable, highly pure L-cysteine compositions for injection and methods of use
Filed: 2019-01-15
Issued: 2019-11-19
Active (12.2 yrs remaining)
Expires: 2039-01-15

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

4

Dispositive

0

Granted

0

Denied

0

Pending / Review

2

Motions by Category

Procedural / Extension Motion 4

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
MOTION for Extension of Time to Answer Complaint - filed by Exela Pharma Sciences, LLC. (Oakes, Robert) Modified on 6/23/2020 (dlw). (Entered: 06/23/2020)
Entry #8 • 2020-06-23 Document →
Procedural / Extension Motion Pending
SO ORDERED re 8 MOTION for Extension of Time to answer, move, or otherwise respond to the Complaint (Set/Reset Answer Deadlines: Avadel Legacy Pharmaceuticals, ...
Entry #β€” • 2020-06-23
Procedural / Extension Motion Pending / Under Review
MOTION for Extension of Time to Answer Complaint - filed by Exela Pharma Sciences, LLC. (Oakes, Robert) (Entered: 05/19/2020)
Entry #7 • 2020-05-19 Document →
Procedural / Extension Motion Pending
SO ORDERED re 7 MOTION for Extension of Time to Answer Complaint (Set/Reset Answer Deadlines: Avadel Legacy Pharmaceuticals, LLC answer due 6/30/2020; Avadel US...
Entry #β€” • 2020-05-19

Docket Entries

(20 total)
Pleading / Complaint

COMPLAINT filed with Jury Demand against Avadel Legacy Pharmaceuticals, LLC, Avadel US Holdings Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-2818819.) - filed by Exela Pharma Sciences, LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Civil Cover Sheet)(myr) (Entered: 01/08/2020)

Entry #1 • 2020-01-07
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) (Entered: 01/08/2020)

Entry #2 • 2020-01-07
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 10,478,453. (myr) (Entered: 01/08/2020)

Entry #3 • 2020-01-07
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Exela PharmSci, Inc., Corporate Parent Exela Holdings, Inc., Corporate Parent Exela PharmSci Private Limited. for Exela Pharma Sciences, LLC filed by Exela Pharma Sciences, LLC. (myr) (Entered: 01/08/2020)

Entry #4 • 2020-01-07
1

No Summons Issued. (myr)

Entry #5 • 2020-01-08
1
No Actions

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc